Active Ingredient Dabrafenib Mesylate

Active Ingredient Details

What is the usage for Dabrafenib Mesylate?

Dabrafenib may be used alone or in combination with another medication (trametinib) to treat a type of skin cancer (melanoma). It is also used with trametinib to treat thyroid cancer and a type of lung cancer (non-small cell lung cancer-NSCLC). Dabrafenib works by slowing the growth of cancer cells.

How many products in the NDC database contain Dabrafenib Mesylate?

The NDC database has 11 products with the active ingredient Dabrafenib Mesylate. The following table lists all the products that have this active ingredient.

NDC Products with Dabrafenib Mesylate

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0078-0681	Proprietary Name: Tafinlar	Dabrafenib	Capsule	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0682	Proprietary Name: Tafinlar	Dabrafenib	Capsule	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-1154	Proprietary Name: Tafinlar	Dabrafenib	Tablet, For Suspension	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
0078-1462	Proprietary Name:	Dabrafenib	Powder		Novartis Pharmaceuticals Corporation	ACTIVE
17088-0212	Proprietary Name:	Dabrafenib	Tablet, For Suspension		Novartis Pharma Stein Ag	ACTIVE
50384-6600	Proprietary Name:	Dabrafenib Mesylate	Powder		Sterling Pharma Solutions Limited	ACTIVE
54893-0052	Proprietary Name:	Dabrafenib Mesylate	Powder		Msn Laboratories Private Limited	ACTIVE
81719-015	Proprietary Name:	Dabrafenib Mesylate	Capsule		Siegfried Barbera, Sl	ACTIVE
81719-016	Proprietary Name:	Dabrafenib Mesylate	Capsule		Siegfried Barbera, Sl	ACTIVE
81955-0029	Proprietary Name:	Dabrafenib Mesylate	Powder		Valary Lab Private Limited	ACTIVE
84644-063	Proprietary Name:	Dabrafenib Mesylate	Powder		Tapi Czech Industries S.r.o.	ACTIVE